Yino Pharma Limited is closed loop EU-GMP certified producer of Heparin range Anticoagulants: Heparin Sodium (EU-GMP), Heparin Calcium (EU-GMP), Enoxaparin Sodium(EU-GMP), Nadroparin Calcium(EU-GMP), Dalteparin Sodium(EU-GMP).Dermatan Sulfate, Heparinoid Sodium and Mucopolysaccharide Polysulfate. Further Heparin derivatives under development.
Best possible implementation of Annex 2 to EU-GMP Guidelines and FDA Guidance for Industry: From intestine to API - all at one site.
Additional facility for biological active substances: Chondroitin Sulfate, Liver Extract, Pancreatin, Lung Surfactant.
more >
Year of Establishment:
2009
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Production Capacity,Buyers' Specifications Accepted,Quality Service
Other Competitive Advantages:
Traceability, Best possible implementation of Annex 2 to EU-GMP Guidelines and FDA Guidance for Industry: From intestine to API - all at one site.
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Other Competitive Advantages:
Traceability, Best possible implementation of Annex 2 to EU-GMP Guidelines and FDA Guidance for Industry: From intestine to API - all at one site.
Patents and Copyrights: